D.A. Davidson & Co’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.63M | Sell |
4,220
-261
| -6% | -$96.8K | 0.01% | 798 |
|
|
2026
Q1 | $1.31M | Sell |
4,481
-1,139
| -20% | -$374K | 0.01% | 835 |
|
|
2025
Q4 | $1.97M | Buy |
5,620
+231
| +4% | +$78.1K | 0.01% | 664 |
|
|
2025
Q3 | $1.74M | Buy |
5,389
+532
| +11% | +$165K | 0.01% | 687 |
|
|
2025
Q2 | $1.89M | Sell |
4,857
-612
| -11% | -$246K | 0.01% | 628 |
|
|
2025
Q1 | $2.38M | Sell |
5,469
-47
| -0.9% | -$18.9K | 0.02% | 523 |
|
|
2024
Q4 | $2.03M | Sell |
5,516
-282
| -5% | -$118K | 0.02% | 563 |
|
|
2024
Q3 | $3.02M | Sell |
5,798
-122
| -2% | -$65.2K | 0.02% | 442 |
|
|
2024
Q2 | $3.21M | Sell |
5,920
-314
| -5% | -$166K | 0.03% | 407 |
|
|
2024
Q1 | $3.23M | Buy |
6,234
+577
| +10% | +$287K | 0.03% | 409 |
|
|
2023
Q4 | $2.67M | Buy |
5,657
+69
| +1% | +$31.9K | 0.03% | 426 |
|
|
2023
Q3 | $2.43M | Sell |
5,588
-63
| -1% | -$28.6K | 0.03% | 421 |
|
|
2023
Q2 | $2.51M | Sell |
5,651
-392
| -6% | -$181K | 0.03% | 424 |
|
|
2023
Q1 | $2.78M | Buy |
6,043
+1,007
| +20% | +$479K | 0.03% | 391 |
|
|
2022
Q4 | $2.58M | Sell |
5,036
-180
| -3% | -$91.4K | 0.03% | 385 |
|
|
2022
Q3 | $2.37M | Buy |
5,216
+48
| +0.9% | +$23K | 0.03% | 380 |
|
|
2022
Q2 | $2.49M | Sell |
5,168
-1,039
| -17% | -$514K | 0.03% | 375 |
|
|
2022
Q1 | $3.05M | Buy |
6,207
+30
| +0.5% | +$13.7K | 0.03% | 364 |
|
|
2021
Q4 | $2.86M | Sell |
6,177
-370
| -6% | -$156K | 0.03% | 374 |
|
|
2021
Q3 | $2.44M | Buy |
6,547
+186
| +3% | +$70.7K | 0.03% | 388 |
|
|
2021
Q2 | $2.43M | Sell |
6,361
-311
| -5% | -$119K | 0.03% | 396 |
|
|
2021
Q1 | $2.4M | Buy |
6,672
+378
| +6% | +$122K | 0.03% | 370 |
|
|
2020
Q4 | $2.02M | Buy |
6,294
+94
| +2% | +$28.8K | 0.03% | 345 |
|
|
2020
Q3 | $1.67M | Sell |
6,200
-22
| -0.4% | -$5.92K | 0.03% | 342 |
|
|
2020
Q2 | $1.64M | Sell |
6,222
-267
| -4% | -$71.2K | 0.03% | 336 |
|
|
2020
Q1 | $1.47M | Sell |
6,489
-47
| -0.7% | -$12.8K | 0.03% | 377 |
|
|
2019
Q4 | $1.97M | Buy |
6,536
+173
| +3% | +$47.6K | 0.03% | 365 |
|
|
2019
Q3 | $1.53M | Buy |
6,363
+7
| +0.1% | +$1.92K | 0.03% | 392 |
|
|
2019
Q2 | $1.79M | Sell |
6,356
-1,546
| -20% | -$422K | 0.03% | 355 |
|
|
2019
Q1 | $2.15M | Sell |
7,902
-527
| -6% | -$152K | 0.04% | 347 |
|
|
2018
Q4 | $2.21M | Sell |
8,429
-275
| -3% | -$75.6K | 0.04% | 314 |
|
|
2018
Q3 | $2.39M | Buy |
8,704
+30
| +0.3% | +$7.79K | 0.04% | 318 |
|
|
2018
Q2 | $2.06M | Buy |
8,674
+190
| +2% | +$44K | 0.04% | 342 |
|
|
2018
Q1 | $1.86M | Sell |
8,484
-453
| -5% | -$106K | 0.04% | 343 |
|
|
2017
Q4 | $2.01M | Buy |
8,937
+2,786
| +45% | +$593K | 0.04% | 317 |
|
|
2017
Q3 | $1.17M | Sell |
6,151
-573
| -9% | -$109K | 0.02% | 458 |
|
|
2017
Q2 | $1.26M | Sell |
6,724
-414
| -6% | -$74.4K | 0.03% | 409 |
|
|
2017
Q1 | $1.18M | Buy |
7,138
+770
| +12% | +$122K | 0.03% | 405 |
|
|
2016
Q4 | $913K | Sell |
6,368
-4,249
| -40% | -$569K | 0.02% | 492 |
|
|
2016
Q3 | $1.33M | Buy |
10,617
+8,194
| +338% | +$1.06M | 0.03% | 394 |
|
|
2016
Q2 | $315K | Buy |
2,423
+643
| +36% | +$88K | 0.01% | 692 |
|
|
2016
Q1 | $244K | Buy |
1,780
+1
| +0.1% | +$134 | 0.01% | 753 |
|
|
2015
Q4 | $245K | Buy |
1,779
+444
| +33% | +$61.2K | 0.01% | 774 |
|
|
2015
Q3 | $183K | Sell |
1,335
-216
| -14% | -$32.5K | 0.01% | 854 |
|
|
2015
Q2 | $252K | Sell |
1,551
-259
| -14% | -$41.4K | 0.01% | 785 |
|
|
2015
Q1 | $276K | Sell |
1,810
-239
| -12% | -$34K | 0.01% | 753 |
|
|
2014
Q4 | $253K | Buy |
2,049
+11
| +0.5% | +$1.36K | 0.01% | 787 |
|
|
2014
Q3 | $242K | Buy |
2,038
+800
| +65% | +$91.8K | 0.01% | 803 |
|
|
2014
Q2 | $131K | Buy |
1,238
+76
| +7% | +$7.83K | ﹤0.01% | 1032 |
|
|
2014
Q1 | $114K | Sell |
1,162
-14
| -1% | -$1.27K | ﹤0.01% | 1067 |
|
|
2013
Q4 | $107K | Buy |
1,176
+954
| +430% | +$84.8K | ﹤0.01% | 1036 |
|
|
2013
Q3 | $17K | Buy |
222
+85
| +62% | +$7.29K | ﹤0.01% | 1373 |
|
|
2013
Q2 | $10K | Buy |
+137
| New | +$10.3K | ﹤0.01% | 1419 |
|
Other funds holding ELV
D.A. Davidson & Co's ELV Position: Q2 2026 in Review
D.A. Davidson & Co reduced its Elevance Health (ELV) stake by 5.8% in Q2 2026, selling an estimated $96.8K and leaving 4,220 shares worth $1.63M. The position accounts for 0.01% of the portfolio, ranked #798.
D.A. Davidson & Co first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.23M in Q1 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- D.A. Davidson & Co held 4,220 shares of Elevance Health worth $1.63M as of Q2 2026.
- D.A. Davidson & Co sold 261 Elevance Health shares in Q2 2026, an estimated $96.8K.
- Elevance Health made up 0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #798 holding.
- D.A. Davidson & Co first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- D.A. Davidson & Co's Elevance Health position peaked at $3.23M in Q1 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.